We're excited to announce our series A funding round. Existing and new investors subscribed to the round for a total worth of $9,3 million (€7,5 milli...

BRUSSELS, BELGIUM and HASSELT, BELGIUM—. UgenTec, the Belgian PCR automation software company is approved for the SME Instrument Phase 1 by the Europe...

UgenTec, the Belgian company that is developing independent PCR analysis software based on artificial intelligence and machine learning, closed a €2.1...

We are proud to announce that we have received more than €1M in venture capital funding from a group of Belgian investors and an additional €250 000 i...